Dr. Hamid Djalilian was part of an invited panel at the American Otological Society where he discussed the state of the art on noise induced hearing loss. He also discussed novel work on mitochondrial transplantation that was pioneered in his laboratory.
For the first time, Dr. Djalilian and his team found that mitochondria can be transplanted into hair cells and can improve the resilience of the hearing cells to oxidative stress. This work has implications for preventing noise induced and age-related hearing loss.
Dr. Djalilian and his team presented their work on “Exploring Otological Comorbidities of Tinnitus in the U.S. Population” and “Gender Difference in Quality of Life in Meniere’s Disease” at the American Otological Society and Triological Society meetings, respectively.
Additionally, a recent publication by Dr. Djalilian and his team has led to a better understanding of the central signs of long COVID (tinnitus, dizziness, head pressure, mental fogginess). The new paper discusses how calcitonin gene related peptide (CGRP) plays a role in central sensitization that is the underlying process of central long COVID. Dr. Djalilian has partnered with a national telehealth clinic (NeuroMed) that is treating tinnitus and central long COVID using protocols developed using Dr. Djalilian’s research.